1.59 USD
↘ 0.05 (3.05%)AT CLOSE (03:59 PM EDT)
Cel-Sci Corporation
CVMAMEX • USD
1.62
↗ 0.03 (2.14%)
POST MARKET (AS OF 07:50 PM EDT)
Post Market
AS OF 07:50 PM EDT
1.62
↗ 0.03 (2.14%)
Market: CLOSED
Cel-Sci Corporation (CVM) trades at $1.59 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest CVM is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 26, 2026.
Open?$1.71
High?$1.83
Low?$1.51
Prev. Close?$1.64
Volume?106.9K
Avg. Volume?232.9K
VWAP?$1.62
Rel. Volume?0.46x
Bid / Ask
Bid?$1.56 × 200
Ask?$2.37 × 300
Spread?$0.81
Midpoint?$1.97
Valuation & Ratios
Market Cap?28.8M
Shares Out?17.5M
Float?16.6M
Float %?95.1%
P/E Ratio?N/A
P/B Ratio?2.63
EPS?-$1.29
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
Themes
Employees
44
Market Cap
28.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1983-12-08
Address
8229 BOONE BLVD .
VIENNA, VA 22182
Phone: (703) 506-9460
VIENNA, VA 22182
Phone: (703) 506-9460
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?50
Piotroski F-Score?0/9Weak
Altman Z-Score?-38.09Distress
Confidence?44%Low
Short InterestLow
Short % of Float?4.00%Low
Short Interest?663.8K
Days to Cover?1.6
Free Float16.6M
Avg Daily Volume412.8K
Settlement Date2026-10-15
Financial Health
Current Ratio?1.48Adequate
Quick Ratio?1.42Adequate
Cash Ratio?1.29Strong
Debt/Equity?0.57Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.63CHEAP▾
Peers100
S&P62
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-207.2%WEAK▾
S&P3
ROA?-106.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-16751398
Enterprise Value?$28.6M
Fundamentals ratios updated end of day